Ali Mohammad, Din Wani Shahid Ud, Manjula S N, Mruthunjaya K, Shakeel Faiyaz, Dr Bharathi, Sridhar Sathvik B, Mohiuddin Ishfaq, Mir Reyaz Hassan, Dey Tathagata
Department of Pharmacology, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Mysuru, 570015, India.
Department of Pharmacology, Sri Adichunchanagiri College of Pharmacy, Adichunchanagiri University, B. G Nagar, Bellur, Karnataka, 571418, India.
Heliyon. 2024 Sep 6;10(18):e37557. doi: 10.1016/j.heliyon.2024.e37557. eCollection 2024 Sep 30.
Cyclophosphamide (CYL) is a first-line cancer chemotherapeutic agent widely used for the treatment of cancer that has severe toxic effects. The primary mechanism by which CYL induces toxicity through free radical generation. (Noni) fruit juice is an herbal remedy documented to have antioxidant properties. The aim of the current study was to investigate the protective effect of noni against CYL-induced memory impairment in Swiss albino mice. Treatment schedule: Group 1: Normal: Received vehicle; Group 2: CYL treatment: Received CYL (40.0 mg/kg b.w. i.p.) on day one; Group 3: NJ treatment: Received NJ (360 mg/b.w. p.o.) once daily for 14 days. Group 4: DNG treatment: DNG (360 mg/b.w. p.o.) once daily for 14 days, Group 5: NJ + CYL treatment: Received CYL (40.0 mg/kg b.w. i.p.) on day one and after half an hour of received NJ (360 mg/b.w. p.o.) once daily for 14 days. Group 6: DNG + CYL treatment: Received CYL (40.0 mg/kg b.w. i.p.) on day one and after half an hour received DNG (360 mg/b.w. p.o.) once daily for 14 days. Mice were subjected to the Morris water maze (MWM) challenge for two weeks as part of a behavioral study. Short-term memory impairment was observed in the behavioral activity of CYL-treated mice in the MWM test in the 1st week trial, and this effect was reversed in the 2nd week trial in the combination treatment group. The behavioral analysis proved that noni supplementation reduced the risk of memory impairment caused by CYL. Biochemical analysis revealed that CYL markedly increased the levels of AChE and MDA in brain tissue. Similarly, decreases in the levels of antioxidants, i.e., GSH, CAT, SOD and GST, were detected in the brain tissue of the mice exposed to CYL. Qualitative and quantitative examinations of histopathological examination of the mouse hippocampus supported the above findings. The results demonstrated that noni supplement therapy reversed the changes in the MDA, AChE, and antioxidant enzyme levels while improving the behavioral and histological alterations caused by CYL. Long-term hippocampal growth and memory are unaffected, suggesting that CYL is less harmful. According to our research, supplementing with noni in conjunction with CYL may be a helpful treatment strategy for treating memory impairment caused by CYL.
环磷酰胺(CYL)是一种一线癌症化疗药物,广泛用于治疗癌症,但具有严重的毒副作用。CYL通过产生自由基诱导毒性的主要机制。诺丽果汁是一种有文献记载具有抗氧化特性的草药疗法。本研究的目的是探讨诺丽对CYL诱导的瑞士白化小鼠记忆障碍的保护作用。治疗方案:第1组:正常组:接受赋形剂;第2组:CYL治疗组:在第1天接受CYL(40.0毫克/千克体重,腹腔注射);第3组:诺丽治疗组:每天口服诺丽(360毫克/体重),共14天。第4组:二氮嗪治疗组:每天口服二氮嗪(360毫克/体重),共14天;第5组:诺丽+CYL治疗组:在第1天接受CYL(40.0毫克/千克体重,腹腔注射),半小时后每天口服诺丽(360毫克/体重),共14天。第6组:二氮嗪+CYL治疗组:在第1天接受CYL(40.0毫克/千克体重,腹腔注射),半小时后每天口服二氮嗪(360毫克/体重),共14天。作为行为学研究的一部分,小鼠接受了两周的莫里斯水迷宫(MWM)挑战。在第1周试验的MWM测试中,观察到CYL处理的小鼠的行为活动出现短期记忆障碍,而在联合治疗组的第2周试验中,这种效应得到逆转。行为分析证明补充诺丽降低了CYL引起的记忆障碍风险。生化分析显示,CYL显著增加了脑组织中乙酰胆碱酯酶(AChE)和丙二醛(MDA)的水平。同样,在暴露于CYL的小鼠脑组织中检测到抗氧化剂水平的降低,即谷胱甘肽(GSH)、过氧化氢酶(CAT)、超氧化物歧化酶(SOD)和谷胱甘肽S-转移酶(GST)。对小鼠海马体的组织病理学检查进行定性和定量检查支持了上述发现。结果表明,诺丽补充疗法逆转了MDA、AChE和抗氧化酶水平的变化,同时改善了CYL引起的行为和组织学改变。长期海马体生长和记忆未受影响,表明CYL的危害较小。根据我们的研究,联合CYL补充诺丽可能是治疗CYL引起的记忆障碍的一种有用治疗策略。